INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV, JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. FILES APPLICATION FOR "COMBINATION THERAPY USING A MALT1 INHIBITOR AND A BTK INHIBITOR"

GENEVA, Dec. 29 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse), JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (2101 & B1-01, No.1 Building, 65 Gui Qing Road, Xuhui DistrictShanghai, Shanghai 20233) filed a patent application (PCT/EP2025/067059) for "COMBINATION THERAPY USING A MALT1 INHIBITOR AND A BTK INHIBITOR" on Jun 18, 2025. With publication no. WO/2025/262118, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FONTAN GABAS, Lorena (Janssen Pharmaceutica NVTurnhoutseweg 302340 Beerse), PHILIPPAR, Ulrike (Janssen ...